Werkgroep Cardiologische centra Nederland English

PROMINENT (Includerend)

Pemafibrate to reduce cardiovascular outcomes by reducing triglycerides in diabetic patients
Middel
pemafibrate
Populatie
diabetes mellitus
Fase
III
Jaar aanvang
2016